CMS grants reimbursement for single-use duodenoscope

CMS grants reimbursement for single-use duodenoscope

Boston Scientific announced CMS granted a new technology add-on payment for single-use duodenoscopes applicable to the EXALT Model D Single-Use Duodenoscope as part of its Fiscal Year 2022 Hospital Inpatient Prospective Payment System.Yearly, clinicians perform more than 700,000 endoscopic retrograde cholangiopancreatography procedures in the U.S. with approximately 1.5 million completed worldwide. The EXALT Model D Single-Use Duodenoscope was designed to eliminate the risk for infection reusable duodenoscopes are prone to. Additional reimbursement for these instruments follows the 2019 FDARead More

Share on facebook
Share on twitter
Share on linkedin